U.S. Office-based Labs Market Size, Share & Trends Report

U.S. Office-based Labs Market Size, Share & Trends Analysis Report By Modality (Hybrid, Multi-specialty), By Service (Cardiac, Endovascular Intervention), By Specialist, And Segment Forecasts, 2022 - 2030

  • Report ID: GVR-2-68038-900-5
  • Number of Pages: 120
  • Format: Electronic (PDF)
  • Historical Range: 2017 - 2020
  • Industry: Healthcare

Table of Contents

Chapter 1 Methodology and Scope
                   1.1 Market Segmentation & Scope
                       1.1.1 Regional Scope
                       1.1.2 Estimates and Forecast Timeline
                   1.2 Research Methodology
                   1.3 Information Procurement
                       1.3.1 Purchased Database
                       1.3.2 GVR’s Internal Database
                       1.3.3 Secondary Sources
                       1.3.4 Primary Research
                       1.3.5 Details of Primary Research
                   1.4 Information or Data Analysis                   
                       1.4.1 Data Analysis Models
                   1.5 Market Formulation & Validation
                   1.6 Model Details
                       1.6.1 Commodity Flow Analysis (Model 1)
                       1.6.2 Volume Price Analysis (Model 2)
                   1.7 List of Secondary Sources
                   1.8 List of Primary Sources
                   1.9 List of Abbreviations
                   1.10 Objectives
                       1.10.1 Objective - 1
                       1.10.2 Objective - 2
                       1.10.3 Objective - 3
Chapter 2 Executive Summary
                   2.1 Market Outlook
                   2.2 Segment Outlook
                       2.2.1 Modality
                       2.2.2 Service
                       2.2.3 Specialist
                   2.3 Competitive Insights
Chapter 3 U.S. Office-Based Labs (OBLs) Market Variables, Trends & Scope
                   3.1 Market Lineage Outlook
                       3.1.1 Parent Market
                       3.1.2 Related/Ancillary Market
                   3.2 U.S. Office-Based Labs (OBLs) Market: Regulatory Framework & Reimbursement Scenario
                       3.2.1 U.S. Office-Based Labs (OBLs) Market: Regulatory Framework
                       3.2.2 U.S. Office-Based Labs (OBLs) Market: Reimbursement Scenario
                   3.3 Market Dynamics
                       3.3.1 Market driver analysis
                           3.3.1.1 Increasing prevalence of target diseases
                           3.3.1.2 Preference for minimally invasive procedures
                       3.3.2 Market restraint analysis
                           3.3.2.1 High-risk option for severe cases
                           3.3.2.2 Lack of technical training for the MIS procedure
                       3.3.3 Industry Opportunities
                           3.3.3.1 Approval of endovascular procedures in office-based labs
                           3.3.3.2 Flexibility for physicians to convert to OBLs
                   3.4 Business Environment Analysis Tools
                       3.4.1 Porter’s five forces analysis
                           3.4.1.1 Competitive rivalry: High
                           3.4.1.2 Threat of new entrants: Moderate
                           3.4.1.3 Bargaining power of buyers: Moderate
                           3.4.1.4 Bargaining power of suppliers: Moderate
                           3.4.1.5 Threat of substitutes: High
                       3.4.2 PESTLE Analysis
                           3.4.2.1 Political & legal landscape
                           3.4.2.2 Economic and social landscape
                           3.4.2.3 Technology landscape
                   3.5 Qualitative Analysis: Impact of COVID-19 on Office Based Labs (OBL)
                   3.6 U.S. Office-Based Labs (OBLs) Market: Penetration & Growth Prospect Mapping
Chapter 4 U.S. Office-Based Labs (OBLs) Market: Modality Analysis
                   4.1 U.S. Office-based Labs (OBLs) Modality Market Share Analysis, 2021 & 2030
                   4.2 U.S. Office-Based Labs (OBLs) Modality Market: Segment Dashboard
                   4.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Modality Segment
                       4.3.1 Single Specialty Labs
                           4.3.1.1 Single specialty labs market, 2017 - 2030 (USD Million)
                       4.3.2 Multi-Specialty Labs
                           4.3.2.1 Multi-specialty labs market, 2017 - 2030 (USD Million)
                       4.3.3 Hybrid Labs
                           4.3.3.1 Hybrid labs market, 2017 - 2030 (USD Million)
                           4.3.3.2 Qualitative analysis: Future trends of hybrid labs
Chapter 5 U.S. Office-Based Labs (OBLs) Market: Service Analysis
                   5.1 U.S. Office-Based Labs (OBLs) Market Service Market Share Analysis, 2021 & 2030
                   5.2 U.S. Office-Based Labs (OBLs) Market Service Market: Segment Dashboard
                   5.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Services
                       5.3.1 Peripheral Vascular Intervention
                           5.3.1.1 Peripheral vascular intervention market, 2017 - 2030 (USD Million)
                       5.3.2 Cardiac
                           5.3.2.1 Cardiac market, 2017 - 2030 (USD Million)
                       5.3.3 Interventional Radiology
                           5.3.3.1 Interventional radiology market, 2017 - 2030 (USD Million)
                       5.3.4 Venous
                           5.3.4.1 Venous market, 2017 - 2030 (USD Million)
                       5.3.5 Endovascular Interventions
                           5.3.5.1 Endovascular interventions market, 2017 - 2030 (USD Million)
                       5.3.6 Others
                           5.3.6.1 Others market, 2017 - 2030 (USD Million)
Chapter 6 U.S. Office-Based Labs (OBLs) Market: Specialist Analysis
                   6.1 U.S. Office-Based Labs (OBLs) Market Specialist Market Share Analysis, 2021 & 2030
                   6.2 U.S. Office-Based Labs (OBLs) Market Specialist Market: Segment Dashboard
                   6.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Specialist
                       6.3.1 Vascular Surgeons
                           6.3.1.1 Vascular surgeons market, 2017 - 2030 (USD Million)
                       6.3.2 Interventional Cardiologists
                           6.3.2.1 Interventional cardiologists market, 2017 - 2030 (USD Million)
                       6.3.3 Interventional Radiologists
                           6.3.3.1 Interventional radiologists market, 2017 - 2030 (USD Million)
                       6.3.4 Other Specialists
                           6.3.4.1 Other specialists market, 2017 - 2030 (USD Million)
Chapter 7 U.S. Office-Based Labs (OBLs) Market: Regional Analysis
                   7.1 U.S. Office-Based Labs (OBLs) Market, 2017-2030 (USD Million)
                   7.2 U.S Office-Based Labs (OBLs) Market: Top 5 States
                       7.2.1 Penetration Analysis: Top 5 states 2021
                   7.3 Pricing Analysis
                       7.3.1 Average cost of major procedures performed in Office-based labs
                       7.3.2 Average cost of major devices used in Office-based labs
                       7.3.3 Average cost of setting up an office-based labs
Chapter 8 Competitive Analysis
                   8.1 Vendor Landscape
                       8.1.1 Partnerships
                       8.1.2 Marketing & promotions
                   8.2 Suppliers
                       8.2.1 Recent Developments & Impact Analysis, by Key Market Participants
                       8.2.2 Company Competition Categorization
                       8.2.3 Company Market Position Analysis: Imaging Devices Manufacturer
                       8.2.4 Company Market Position Analysis: Vascular Intervention Devices
                   8.3 Service Providers
                       8.3.1 Company Market Position Analysis
                   8.4 Suppliers Company Profiles
                       8.4.1 Koninklijke Philips N.V
                           8.4.1.1 Company overview
                           8.4.1.2 Financial performance
                           8.4.1.3 Product benchmarking
                           8.4.1.4 Strategic initiatives
                           8.4.1.5 SWOT analysis
                       8.4.2 GE Healthcare
                           8.4.2.1 Company overview
                           8.4.2.2 Financial performance
                           8.4.2.3 Product benchmarking
                           8.4.2.4 Strategic initiatives
                           8.4.2.5 SWOT analysis
                       8.4.3 Siemens Healthineers AG
                           8.4.3.1 Company overview
                           8.4.3.2 Financial performance
                           8.4.3.3 Product benchmarking
                           8.4.3.4 Strategic initiatives
                           8.4.3.5 SWOT analysis
                       8.4.4 Medtronic PLC
                           8.4.4.1 Company overview
                           8.4.4.2 Financial performance
                           8.4.4.3 Product benchmarking
                           8.4.4.4 Strategic initiatives
                           8.4.4.5 SWOT analysis
                       8.4.5 Boston Scientific Corporation
                           8.4.5.1 Company overview
                           8.4.5.2 Financial performance
                           8.4.5.3 Product benchmarking
                           8.4.5.4 Strategic initiatives
                           8.4.5.5 SWOT analysis
                       8.4.6 Abbott
                           8.4.6.1 Company overview
                           8.4.6.2 Financial performance
                           8.4.6.3 Product benchmarking
                           8.4.6.4 Strategic initiatives
                           8.4.6.5 SWOT analysis
                       8.4.7 Cardiovascular Systems, Inc.
                           8.4.7.1 Company overview
                           8.4.7.2 Financial performance
                           8.4.7.3 Product benchmarking
                           8.4.7.4 Strategic initiatives
                           8.4.7.5 SWOT analysis
                   8.5 Service Providers Company Profiles
                       8.5.1 Envision Healthcare Corporation
                           8.5.1.1 Company overview
                           8.5.1.2 Financial performance
                           8.5.1.3 Service benchmarking
                           8.5.1.4 Strategic initiatives
                           8.5.1.5 SWOT analysis
                       8.5.2 Surgical Care Affiliates (SCA)
                           8.5.2.1 Company overview
                           8.5.2.2 Financial performance
                           8.5.2.3 Service benchmarking
                           8.5.2.4 Strategic initiatives
                           8.5.2.5 SWOT analysis
                       8.5.3 Fresenius Medical Care
                           8.5.3.1 Company overview
                           8.5.3.2 Financial performance
                           8.5.3.3 Service benchmarking
                           8.5.3.4 SWOT analysis
                       8.5.4 Cardiovascular Coalition
                           8.5.4.1 Company overview
                           8.5.4.2 Service benchmarking
                       8.5.5 Surgery Partners
                           8.5.5.1 Company overview
                           8.5.5.2 Financial performance
                           8.5.5.3 Service benchmarking
                           8.5.5.4 Strategic Initiatives
                           8.5.5.5 SWOT analysis
                       8.5.6 TH Medical
                           8.5.6.1 Company overview
                           8.5.6.2 Financial performance
                           8.5.6.3 Service benchmarking
                           8.5.6.4 Strategic initiatives
                           8.5.6.5 SWOT analysis
Chapter 9 KOL Comments & Recommendations
                   9.1 KOL Commentary
                   9.2 Recommendations


List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Procedure codes and physician reimbursement, 2021
Table 4 Shifting trends from the inpatient facility to the outpatient facility
Table 5 U.S. Office-Based Labs Market, by Modality, 2017 - 2030 (USD Million)
Table 6 U.S. Office-Based Labs Market, by Services, 2017 - 2030 (USD Million)
Table 7 U.S. Office-Based Labs Market, by Specialists, 2017 - 2030 (USD Million)


List of Figures

Fig. 1 U.S. Office-Based Labs (OBLs) market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook, 2021 (USD Million)
Fig. 10 Market dynamics & trends analysis
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 U.S. Office-Based Labs (OBLs) market: Penetration & growth prospect mapping
Fig. 14 U.S. Office-Based Labs (OBLs) modality market share analysis, (USD Million)
Fig. 15 U.S. Office-Based Labs (OBLs) modality market: Segment dashboard (USD Million)
Fig. 16 Single specialty labs market, 2017 - 2030 (USD Million)
Fig. 17 Multi-specialty labs market, 2017 - 2030 (USD Million)
Fig. 18 Hybrid labs market, 2017 - 2030 (USD Million)
Fig. 19 U.S. Office-Based Labs (OBLs) market service movement analysis, (USD Million)
Fig. 20 U.S. Office-Based Labs (OBLs) market service market: Segment dashboard (USD Million)
Fig. 21 Peripheral vascular intervention market, 2017 - 2030 (USD Million)
Fig. 22 Cardiac market, 2017 - 2030 (USD Million)
Fig. 23 Interventional radiology market, 2017 - 2030 (USD Million)
Fig. 24 Venous market, 2017 - 2030 (USD Million)
Fig. 25 Endovascular interventions market, 2017 - 2030 (USD Million)
Fig. 26 Other services market, 2017 - 2030 (USD Million)
Fig. 27 U.S. Office-Based Labs (OBLs) market specialist movement analysis, (USD Million)
Fig. 28 U.S. Office-Based Labs (OBLs) market specialist market: Segment dashboard (USD Million)
Fig. 29 Vascular surgeons market, 2017 - 2030 (USD Million)
Fig. 30 Interventional cardiologists market, 2017 - 2030 (USD Million)
Fig. 31 Interventional radiologists market, 2017 - 2030 (USD Million)
Fig. 32 Other specialists market, 2017 - 2030 (USD Million)
Fig. 33 Penetration analysis: Top 5 states 2021
Fig. 34 Recent developments & impact analysis, by key market participants
Fig. 35 Company competition categorization
Fig. 36 Company market position analysis (Imaging devices manufacturer)
Fig. 37 Company market position analysis (Vascular intervention devices)
Fig. 38 Company market position analysis: Service providers

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.